Pharmacotherapy for obesity in menopausal women |
| |
Authors: | Samat Ashish Rahim Asad Barnett Anthony |
| |
Institution: | Department of Diabetes and Endocrinology, Birmingham Heartlands Hospital, Birmingham, UK. ashishsamat@hotmail.com |
| |
Abstract: | Weight gain, during and after the menopause is common. Contributing factors include ethnicity, reduced physical activity, reduced lean mass, reduced resting metabolic rate and treatment with certain drugs, e.g. steroids, insulin, glitazones. Excess body weight increases the risk of medical conditions including type 2 diabetes, hypertension, osteoarthritis, certain cancers and is associated with increased mortality. This review examines pharmacological approaches to promote weight loss. Pharmacological therapy should be considered as an adjunct to diet and lifestyle changes. The licensed drugs orlistat, sibutramine and rimonabant are discussed. Obesity increases the risk of type 2 diabetes. Thus, the effects of metformin and exenatide are examined. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|